Immunological evaluation of the new stable ultrasound contrast agent LK565: A phase one clinical trial

Cardiovascular Ultrasound

Volumn 2, Issue , 2004, Pages

  Funke, B ^a   Maerz, H K ^a   Okorokow, S ^b   Polata, S ^b   Lehmann, I ^b   Sack, U ^b   Wild, P ^a   Geisler, T ^a   Zotz, R J ^a  

^a Klinikum Schwalmstadt   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; LK 565;

ANAPHYLAXIS; ANTIBODY PRODUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC VALUE; DRUG METABOLISM; DRUG RESPONSE; DRUG SAFETY; DRUG STABILITY; ECHOCARDIOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; LEUKOCYTE ACTIVATION; MONOCYTE; PHAGOCYTE; PHAGOCYTOSIS; RISK REDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; ASPARTIC ACID; CONTRAST MEDIA; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; MALE; MICROSPHERES; PHAGOCYTOSIS; VASCULITIS;

EID: 5444234208     PISSN: 14767120     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-7120-2-16     Document Type: Article

References (21)

1. Feinstein SB: Myocardial perfusion: contrast echocardiography perspectives. Am J Cardiol 1992, 69:36H-41H.
2. Meltzer RS, Tickner EG, Sahines TP, Popp R: The source of ultrasound contrast effect. J Clin Ultrasound 1980, 8:121-127.
3. Cheng SC, Dy TC, Feinstein SB: Contrast echocardiography: review and future directions. Am J Cardiol 1998, 81:41G-48G.
4. Smith MD, Kwan OL, Reiser HJ, DeMaria AN: Superior intensity and reproducibility of SHU-454, a new right heart contrast agent. J Am Coll Cardiol 1984, 3:992-998.
5. Keller MW, Glasheen W, Kaul S: Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography. J Am Soc Echocardiogr 1989, 2:48-52.
6. Zotz RJ, Genth S, Erbel R, Dieterich HA, Meyer J: Contrast echocardiography of the left ventricle an independent predictor of pulmonary artery pressure? Int J Card Imaging 1994, 10:195-203.
7. Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R, Yan F: BR1: a new ultrasonographic contrast agent based on sulfur hexafluoridefilled microbubbles. Invest Radiol 1995, 30:451-457.
8. Grayburn P: Perflenapent emulsion (EchoGen): a long-acting phase shift agent for contrast echocardiography. Clin Cardiol 1997, 20(10 Suppl 1):112-118.
9. Cohen JL, Cheirif J, Segar DS, Gillam LID, Gottdiener JS, Hausnerova E, Bruns DE: Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase-III multicenter trial. J Am Coll Cardiol 1998, 32:746-752.
10. Zotz R, Genth S, Grande J, Walch A, Ziehn P, Krone V, Schuler G: Polymer microparticles for right and left heart echocardiography and imaging myocardial perfusion after peripheral vein injection. Z Kardiol 1996, 85:924-931.
11. Zotz RJ, Schenk S, Kuhn A, Schlunken S, Krone V, Bruns W, Genth S, Schuler G: Safety and efficacy of LK565 - a new polymer ultrasound contrast medium. Z Kardiol 2001, 90(6):419-26.
12. Maerz HK, Okorokow S, Polata S, Lehmann I, Schneider P, Zotz R: The Fate of ECHO Beads II - Immunological Response or Not? Immunbiol 1999, 200:361.
13. Morrissette N, Gold E, Aderem A: The macrophage - a cell for all seasons. Trends Biol 1999, 9:199-210.
14. Hofsli E, Bakke O, Nonstad U, Espevik T: A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol 1989, 122:405-415.
15. Testi R, D'Ambrosio D, De Maria R, Santoni A: The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994, 15:479-483.
16. Werfel T, Boeker M, Kapp A: Rapid expression of the CD69 antigen on T cells and Natural Killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy 1997, 52:465-469.
17. Arva E, Andersson B: Kinetics of cytokine release and expression of lymphocyte cell-surface activation markers after in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand J Immunol 1999, 49:237-243.
18. Prieto J, Beatty PG, Clark EA, Patarroyo M: Molecule mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cells. Immunology 1988, 63:631-637.
19. Thompson HL, Matsushima K: Human polymorphonuclear leukocytes stimulated by tumour necrosis factor-alpha show increased adherence to extracellular matrix proteins which is mediated via the CD11b 18 complex. Clin Exp Immunol 1992, 90:280-285.
20. Craston R, Koh M, McDermott A, Ray N, Prentice HG, Lowdell MW: Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Meth 1997, 209:37-45.
21. Lundgren-Akerlund E, Olofsson AM, Berger E, Arfors KE: CD11b/CD18-dependent polymorphnuclear leukocyte interaction with matrix proteins in adhesion and migration. Scand J Immunol 1993, 37:569-574.